Table 1.
PC-NTDs targeted by the WHO 2021–2030 roadmap
| Name of the NTD | Level of targeted control | Drugs of choice for MDA | Recommended target group for MDA |
| Lymphatic filariasis | Elimination as a PH problem | Albendazole, diethylcarbamazine, ivermectin | Entire community in endemic areas |
| Onchocerciasis | Elimination (interruption of transmission) | Ivermectin | Entire community in endemic areas |
| Schistosomiasis | Elimination as a PH problem | Praziquantel | At-risk groups: mainly school age children, also recommended for preschool age children and adults in high-risk occupations In highly endemic areas: entire community |
| Soil-transmitted helminthiases | Elimination as a PH problem | Albendazole/mebendazole (intestinal parasites and hookworms) and ivermectin (if Strongyloides present or high prevalence Trichuris) | At-risk groups: mainly school age children, also recommended for preschool age children, women of reproductive age and adults in high-risk occupations |
| Trachoma | Elimination as a PH problem | Azithromycin, tetracycline eye ointment | Entire community in endemic areas |
| Foodborne trematodiases | Intensified control | Triclabendazole (fasciola), praziquantel (others) | Entire community in highly endemic areas |
| Leprosy | Elimination (interruption of transmission) | Rifampicin | Contacts of confirmed cases (postexposure prophylaxis) |
| Scabies | Intensified control | Ivermectin | Entire community in highly endemic areas |
| Taeniasis and cysticercosis | Intensified control | Praziquantel, niclosamide, albendazole | Entire community in endemic areas |
| Yaws | Eradication | Azithromycin | Entire community in endemic areas |
MDA, mass drug administration; NTDs, neglected tropical diseases ; PC, preventive chemotherapy; PH, public health.